Pannone Corporate launches menopause offering
Pannone Corporate

Pannone Corporate has strengthened its HR and employment law offering for businesses with the launch of a menopause toolkit.

The menopause toolkit will provide employers with a package of materials and legal support to ensure businesses can provide meaningful support to employees managing symptoms of the menopause. 

The launch follows a lengthy inquiry by the House of Commons’ Women and Equalities Committee (WEC) into menopause and the workplace at which Pannone Corporate gave evidence, providing legal insight from an employer’s perspective to illuminate best practice and shared challenges.

According to the WEC, almost a million women in the UK have left jobs as a result of menopausal symptoms. A recent survey commissioned by the committee also found that nearly a third of women miss work due to menopause symptoms and that the vast majority don’t ask for support, mainly because of concerns about how others may react.

The Pannone Corporate menopause toolkit includes an initial assessment of current relevant policies and procedures, a menopause policy which is tailored to each individual business and their needs, guidance for managers, delivery of staff training alongside the policy launch, and a six-month review meeting.

Chloe Pugh, an employment associate at Pannone Corporate, said: “The menopause is a topic that is being discussed in public arenas more than ever before and the subject is, quite rightly, becoming less of a taboo. As awareness of this issue increases, it is important that employers create a culture where staff feel they can request, and will get, support with any menopause related issues they are facing. A failure to deal with such requests appropriately or at all could result in businesses losing valuable employees and potentially facing tribunal claims for sex, age or disability discrimination.”

If you are interested in getting the menopause toolkit for your business, please get in touch with Fiona Hamor on or call (0)7717 342049

Back to homepage